For Immediate Release: January 31, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, Brian King, director of the Food and Drug Administration’s Center for Tobacco Products (CTP), …
For Immediate Release: January 31, 2023 Statement From: Robert M. Califf, M.D., MACC Commissioner of Food and Drugs - Food and Drug Administration As the oldest comprehensive consumer protection agency in the country, for more than a century the U.S. Food …
For Immediate Release: January 30, 2023 Today, the U.S. District Court for the Southern District of Florida entered a consent decree of permanent injunction against LGM Pharma LLC, an importer and distributor of active pharmaceutical ingredients (API), …
For Immediate Release: January 27, 2023 The U.S. Food and Drug Administration today announced it is proposing a change from time-based deferrals to assessing blood donor eligibility using gender-inclusive, individual risk-based questions to reduce the risk …
For Immediate Release: January 26, 2023 Statement From: Janet Woodcock, M.D. Principal Deputy Commissioner - Office of the Commissioner Given the growing cannabidiol (CBD) products market, the U.S. Food and Drug Administration convened a high-level …
For Immediate Release: January 24, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA issued a final guidance “Cannabis and Cannabis-Derived Compounds: Quality …
FDA News Release Company Must Stop Marketing Unauthorized Products or Risk Enforcement For Immediate Release: January 24, 2023 Today, the U.S. Food and Drug Administration issued marketing denial orders (MDOs) for two menthol e-cigarette products currently …
For Immediate Release: January 24, 2023 Today, the U.S. Food and Drug Administration is announcing draft guidance for industry on action levels for lead in processed foods that are intended for babies and children under two years of age, to help reduce …
For Immediate Release: January 20, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an immediately-in-effect guidance on compounding certain ibuprofen products in …
For Immediate Release: January 13, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA released a fact sheet and constituent update to remind produce stakeholders of the …
For Immediate Release: December 01, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA rolled out new tools and FAQs to continue to inform stakeholders about the Food …
For Immediate Release: January 10, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued the final guidance for the Foreign Supplier Verification Programs for Importers …
For Immediate Release: September 01, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA cleared for marketing the updated 23andMe Personal Genome Service (PGS) Genetic …
For Immediate Release: August 30, 2023 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) emitió cartas de advertencia a tres fabricantes de fórmula infantil como parte del compromiso continuo …
For Immediate Release: August 01, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA and the Drug Enforcement Administration provided an update on the ongoing actions being …
For Immediate Release: January 06, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA posted an update that the agency is closely monitoring the emergence of the XBB.1.5 …
For Immediate Release: January 06, 2023 Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications …
FDA News Release First Approval for Cats Under Conditional Approval Pathway For Immediate Release: May 01, 2023 Today, the U.S. Food and Drug Administration conditionally approved Varenzin-CA1 (molidustat oral suspension), the first drug for the control of …
For Immediate Release: February 01, 2023 Today, the U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia (decreased number of red blood cells) caused by chronic kidney disease for adults who have …
For Immediate Release: December 30, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced, through a Constituent Update and corresponding rule in the Federal Register, …
